QA: Trisalus Life Sciences Inc in us_health_services/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001826667_2026_Trisalus_Life_Sciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001826667, Trisalus Life Sciences Inc

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 1,279,000
2 AssetsCurrent 32,244,000
3 PropertyPlantAndEquipment 1,808,000
4 remainder_Assets 0
5 LongTermLiabilities 33,046,000
6 LiabilitiesCurrent 11,499,000
7 remainder_Liabilities 24,647,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 6,965,000
10 GeneralAndAdministrativeExpense 21,458,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 28,709,000
15 ResearchAndDevelopmentExpense 14,965,000
16 remainder_Expenses 8,294,000
17 remainder_Revenues 45,151,000
18 remainder_NetIncome -3,987,000
19 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 35,331,000
1 Liabilities 69,192,000
2 Expenses 80,391,000
3 Revenues 45,151,000
4 StockholdersEquity -33,861,000
5 NetIncome -39,227,000
6 ComprehensiveNetIncome -39,227,000
7 BaseVar 117,026,000
8 EconomicCapitalRatiobeforeLimitedLiability -1.69
9 EconomicCapitalRatio 0.483

Edgar->Model Mapping

Feature Distribution

Change over Time